rs61733890
Variant names:
Variant summary
Our verdict is Benign. The variant received -19 ACMG points: 0P and 19B. BP4_ModerateBP6_Very_StrongBP7BS1BS2
The NM_002055.5(GFAP):c.957G>A(p.Arg319Arg) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000812 in 1,613,236 control chromosomes in the GnomAD database, including 11 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.0046 ( 7 hom., cov: 32)
Exomes 𝑓: 0.00041 ( 4 hom. )
Consequence
GFAP
NM_002055.5 synonymous
NM_002055.5 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.369
Publications
1 publications found
Genes affected
GFAP (HGNC:4235): (glial fibrillary acidic protein) This gene encodes one of the major intermediate filament proteins of mature astrocytes. It is used as a marker to distinguish astrocytes from other glial cells during development. Mutations in this gene cause Alexander disease, a rare disorder of astrocytes in the central nervous system. Alternative splicing results in multiple transcript variants encoding distinct isoforms. [provided by RefSeq, Oct 2008]
GFAP Gene-Disease associations (from GenCC):
- Alexander diseaseInheritance: AD Classification: DEFINITIVE, STRONG Submitted by: ClinGen, Genomics England PanelApp, Labcorp Genetics (formerly Invitae), G2P
- Alexander disease type IIInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -19 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.45).
BP6
Variant 17-44911406-C-T is Benign according to our data. Variant chr17-44911406-C-T is described in ClinVar as Benign. ClinVar VariationId is 323611.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=0.369 with no splicing effect.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.00465 (708/152360) while in subpopulation AFR AF = 0.0167 (693/41594). AF 95% confidence interval is 0.0156. There are 7 homozygotes in GnomAd4. There are 342 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High AC in GnomAd4 at 708 AD gene.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| GFAP | NM_002055.5 | c.957G>A | p.Arg319Arg | synonymous_variant | Exon 6 of 9 | ENST00000588735.3 | NP_002046.1 | |
| GFAP | NM_001363846.2 | c.957G>A | p.Arg319Arg | synonymous_variant | Exon 6 of 10 | NP_001350775.1 | ||
| GFAP | NM_001242376.3 | c.957G>A | p.Arg319Arg | synonymous_variant | Exon 6 of 7 | NP_001229305.1 | ||
| GFAP | NM_001131019.3 | c.957G>A | p.Arg319Arg | synonymous_variant | Exon 6 of 8 | NP_001124491.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00464 AC: 707AN: 152242Hom.: 7 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
707
AN:
152242
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.00107 AC: 269AN: 250648 AF XY: 0.000848 show subpopulations
GnomAD2 exomes
AF:
AC:
269
AN:
250648
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000412 AC: 602AN: 1460876Hom.: 4 Cov.: 33 AF XY: 0.000376 AC XY: 273AN XY: 726672 show subpopulations
GnomAD4 exome
AF:
AC:
602
AN:
1460876
Hom.:
Cov.:
33
AF XY:
AC XY:
273
AN XY:
726672
show subpopulations
African (AFR)
AF:
AC:
533
AN:
33468
American (AMR)
AF:
AC:
21
AN:
44704
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
26104
East Asian (EAS)
AF:
AC:
0
AN:
39698
South Asian (SAS)
AF:
AC:
3
AN:
86214
European-Finnish (FIN)
AF:
AC:
0
AN:
53186
Middle Eastern (MID)
AF:
AC:
0
AN:
5512
European-Non Finnish (NFE)
AF:
AC:
4
AN:
1111656
Other (OTH)
AF:
AC:
41
AN:
60334
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.482
Heterozygous variant carriers
0
39
78
118
157
196
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.00465 AC: 708AN: 152360Hom.: 7 Cov.: 32 AF XY: 0.00459 AC XY: 342AN XY: 74508 show subpopulations
GnomAD4 genome
AF:
AC:
708
AN:
152360
Hom.:
Cov.:
32
AF XY:
AC XY:
342
AN XY:
74508
show subpopulations
African (AFR)
AF:
AC:
693
AN:
41594
American (AMR)
AF:
AC:
7
AN:
15306
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
3472
East Asian (EAS)
AF:
AC:
0
AN:
5188
South Asian (SAS)
AF:
AC:
0
AN:
4830
European-Finnish (FIN)
AF:
AC:
0
AN:
10630
Middle Eastern (MID)
AF:
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
AC:
3
AN:
68022
Other (OTH)
AF:
AC:
5
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.498
Heterozygous variant carriers
0
39
79
118
158
197
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
3
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Sep 07, 2017
Athena Diagnostics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Dec 23, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Alexander disease Benign:1
Sep 18, 2023
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.